ArticleThe Journal of urology2017

Re: Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients with Intermediate- or Poor-Risk Germ Cell Tumors.

Jerome P RichiePubMed ↗Publisher ↗

No numbers read from the abstract.